Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.

Arellano ML, Thirman MJ, DiPersio JF, Heiblig M, Stein EM, Schuh AC, Žučenka A, de Botton S, Grove CS, Mannis GN, Papayannidis C, Perl AE, Issa GC, Aldoss I, Bajel A, Dickens DS, Kühn MWM, Mantzaris I, Raffoux E, Traer E, Amitai I, Döhner H, Greco C, Kovacsovics T, McMahon CM, Montesinos P, Pigneux A, Shami PJ, Stone RM, Wolach O, Harpel JG, Chudnovsky Y, Yu L, Bagley RG, Smith AR, Blachly JS

Open source

DOI: 10.1182/blood.2025028357
Published: 2025 Aug 28
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025028357,
  title = {Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.},
  author = {Arellano ML and Thirman MJ and DiPersio JF and Heiblig M and Stein EM and Schuh AC and Žučenka A and de Botton S and Grove CS and Mannis GN and Papayannidis C and Perl AE and Issa GC and Aldoss I and Bajel A and Dickens DS and Kühn MWM and Mantzaris I and Raffoux E and Traer E and Amitai I and Döhner H and Greco C and Kovacsovics T and McMahon CM and Montesinos P and Pigneux A and Shami PJ and Stone RM and Wolach O and Harpel JG and Chudnovsky Y and Yu L and Bagley RG and Smith AR and Blachly JS},
  year = {2025},
  journal = {Blood},
  doi = {10.1182/blood.2025028357},
  url = {https://doi.org/10.1182/blood.2025028357}
}

RIS

TY  - JOUR
TI  - Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.
AU  - Arellano ML
AU  - Thirman MJ
AU  - DiPersio JF
AU  - Heiblig M
AU  - Stein EM
AU  - Schuh AC
AU  - Žučenka A
AU  - de Botton S
AU  - Grove CS
AU  - Mannis GN
AU  - Papayannidis C
AU  - Perl AE
AU  - Issa GC
AU  - Aldoss I
AU  - Bajel A
AU  - Dickens DS
AU  - Kühn MWM
AU  - Mantzaris I
AU  - Raffoux E
AU  - Traer E
AU  - Amitai I
AU  - Döhner H
AU  - Greco C
AU  - Kovacsovics T
AU  - McMahon CM
AU  - Montesinos P
AU  - Pigneux A
AU  - Shami PJ
AU  - Stone RM
AU  - Wolach O
AU  - Harpel JG
AU  - Chudnovsky Y
AU  - Yu L
AU  - Bagley RG
AU  - Smith AR
AU  - Blachly JS
PY  - 2025
JO  - Blood
DO  - 10.1182/blood.2025028357
UR  - https://doi.org/10.1182/blood.2025028357
ER  -

APA

ML, A., MJ, T., JF, D., M, H., EM, S., AC, S., A, Ž., S, D. B., CS, G., GN, M., C, P., AE, P., GC, I., I, A., A, B., DS, D., MWM, K., I, M., E, R., E, T., I, A., H, D., C, G., T, K., CM, M., P, M., A, P., PJ, S., RM, S., O, W., JG, H., Y, C., L, Y., RG, B., AR, S., & JS, B. (2025). Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.. Blood. https://doi.org/10.1182/blood.2025028357

Source records

pubmed · retrieved 2026-09-26T15:56:58.154Z